5 IBD 50s Offer Triple-Digit Earnings Growth Views
As earnings seasons kicks into gear, here are the top five IBD 50 stocks expected to bring in the biggest year-over-year profit gains. The IBD 50 rounds up the best and brightest stocks that boast top fundamentals and strong relative price strength. Cambrex Life sciences firm Cambrex (CBM) offers services and products related to generic and branded pharmaceuticals. After registering 78% earnings growth in Q4 and 22% in Q3, the company is expected